» Articles » PMID: 17360900

Erythropoietin Enhances Hippocampal Response During Memory Retrieval in Humans

Overview
Journal J Neurosci
Specialty Neurology
Date 2007 Mar 16
PMID 17360900
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Although erythropoietin (Epo) is best known for its effects on erythropoiesis, recent evidence suggests that it also has neurotrophic and neuroprotective properties in animal models of hippocampal function. Such an action in humans would make it an intriguing novel compound for the treatment of neurological and psychiatric disorders. The current study therefore aimed to explore the effects of Epo on neural and behavioral measures of hippocampal function in humans using a functional magnetic resonance imaging paradigm. Volunteers were randomized to receive intravenous injection of Epo (40,000 IU) or saline in a between-subjects, double-blind, randomized design. Neural response during picture encoding and retrieval was tested 1 week later. Epo increased hippocampus response during picture retrieval (n = 11) compared with placebo (n = 12; p = 0.04) independent of changes in hematocrit. This is consistent with upregulation of hippocampal BDNF and neurotrophic actions found in animals and highlights Epo as a promising candidate for treatment of psychiatric disorders.

Citing Articles

Darbepoetin alpha has an anxiolytic and anti-neuroinflammatory effect in male rats.

Caliskan H, Onal D, Nalcaci E BMC Immunol. 2024; 25(1):75.

PMID: 39523336 PMC: 11552158. DOI: 10.1186/s12865-024-00665-5.


Effects of cognitive training under hypoxia on cognitive proficiency and neuroplasticity in remitted patients with mood disorders and healthy individuals: ALTIBRAIN study protocol for a randomized controlled trial.

Miskowiak K, Damgaard V, Schandorff J, Macoveanu J, Knudsen G, Johansen A Trials. 2024; 25(1):648.

PMID: 39363230 PMC: 11447976. DOI: 10.1186/s13063-024-08463-5.


Role of erythropoietin in the treatment of Alzheimer's disease: the story so far.

Kalluru P, Bhavanthi S, Vashist S, Gopavaram R, Mamilla M, Sharma S Ann Med Surg (Lond). 2024; 86(6):3608-3614.

PMID: 38846819 PMC: 11152865. DOI: 10.1097/MS9.0000000000002113.


Synergism of Carbamoylated Erythropoietin and Insulin-like Growth Factor-1 in Immediate Early Gene Expression.

Rothschadl M, Sathyanesan M, Newton S Life (Basel). 2023; 13(9).

PMID: 37763230 PMC: 10532867. DOI: 10.3390/life13091826.


Erythropoietin re-wires cognition-associated transcriptional networks.

Singh M, Zhao Y, Daguano Gastaldi V, Wojcik S, Curto Y, Kawaguchi R Nat Commun. 2023; 14(1):4777.

PMID: 37604818 PMC: 10442354. DOI: 10.1038/s41467-023-40332-8.


References
1.
Lupien S, De Leon M, De Santi S, Convit A, Tarshish C, Nair N . Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci. 1999; 1(1):69-73. DOI: 10.1038/271. View

2.
Lancaster J, Woldorff M, Parsons L, Liotti M, Freitas C, Rainey L . Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp. 2000; 10(3):120-31. PMC: 6871915. DOI: 10.1002/1097-0193(200007)10:3<120::aid-hbm30>3.0.co;2-8. View

3.
Brines M, Ghezzi P, Keenan S, Agnello D, De Lanerolle N, Cerami C . Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A. 2000; 97(19):10526-31. PMC: 27058. DOI: 10.1073/pnas.97.19.10526. View

4.
Jenkinson M, Smith S . A global optimisation method for robust affine registration of brain images. Med Image Anal. 2001; 5(2):143-56. DOI: 10.1016/s1361-8415(01)00036-6. View

5.
Birn R, Cox R, Bandettini P . Detection versus estimation in event-related fMRI: choosing the optimal stimulus timing. Neuroimage. 2002; 15(1):252-64. DOI: 10.1006/nimg.2001.0964. View